Substantive outcome improvement and savings to Medicaid may be achieved with small changes in prescribing rates or comorbidity prevalence among patients with heart failure.
Ian M. Breunig, PhD
Advertisement
Articles by Ian M. Breunig, PhD
Advertisement
Latest Updated Articles
- Disease-Modifying Therapy and Hospitalization Risk in Heart Failure Patients
Published: January 20th 2015 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
3
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
4
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
5
